All compounds

A label commonly used for modified GRF(1–29), distinct from the albumin-binding CJC-1295 studied in published trials.

An investigational peptide that some people ask about in relation to ageing biology and sleep rhythms.

A peptide studied in some countries for neurological questions; evidence does not establish general cognitive benefit.

A thymosin beta-4-associated product whose identity and human evidence must not be assumed from its marketing name.